| SNDX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SNDX shares outstanding history going back to 3/3/2016:
Also see: SNDX Market Cap History SNDX YTD Return |
SNDX Shares Outstanding History — Syndax Pharmaceuticals Share Count Over Time
As of 7/31/2026 Syndax Pharmaceuticals has 89.30 million SNDX shares outstanding. Investors often track the SNDX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SNDX share count trends over time, with 43 historical shares outstanding datapoints presented, dating back to 3/3/2016.
| SNDX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNDX Historical Shares Outstanding: +17.02% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SNDX Stock Price Chart |
| About Syndax Pharmaceuticals Inc |
| Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing pipeline of cancer therapies. Its product candidates include revumenib, and axatilimab. It is developing revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia and acute myeloid leukemia (AML), and necleophosmin 1, also known as NPM1, mutant A. It is also exploring the use of revumenib as a treatment in solid tumors, specifically its activity in metastatic colorectal cancer. We show 43 historical shares outstanding datapoints in our coverage of SNDX's shares outstanding history. Understanding the changing numbers of SNDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SNDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SNDX by allowing them to research SNDX shares outstanding history as well as any other stock in our coverage universe. |
| SNDX Current Stock Quote |
Quotes delayed 20 minutes  Free SNDX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SNDX Share Performance |
| Shares Outstanding Peers |
| Syndax Pharmaceuticals (SNDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SNES Shares Outstanding History SNGX Shares Outstanding History SNNA Shares Outstanding History SNOA Shares Outstanding History SNPX Shares Outstanding History SNSE Shares Outstanding History SNSS Shares Outstanding History SOLV Shares Outstanding History SOLY Shares Outstanding History SONN Shares Outstanding History More Healthcare companies » |
SNDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
